| Report ID | 276029 |
| Drug Identification Number | 02220261 |
| Brand name | PENICILLIN G SODIUM FOR INJECTION, USP |
| Common or Proper name | Penicillin G Sodium for Injection, USP 1 million units vial |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | PENICILLIN G |
| Strength(s) | 1000000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 1 MIU |
| ATC code | J01CE |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2026-01-14 |
| Estimated end date | 2026-02-09 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-01-14 |
| Company comments | Fresenius Kabi Canada regrets to advise that we have encountered a supply interruption on our Penicillin G Sodium for Injection, USP 1 million units, vial 15 mL effective immediately, until February 9, 2026. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-01-14 | French | Compare |
| v1 | 2026-01-14 | English | Compare |
Showing 1 to 2 of 2